Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria-Reference-Cited by-同舟云学术

Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria

Published:2021-06 Issue: Volume:334 Page:224-236
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Agbo Chinazom Precious,Ugwuanyi Timothy Chukwuebuka,Ugwuoke Wilfred Ikechukwu,McConville Christopher,Attama Anthony Amaechi,Ofokansi Kenneth Chibuzor

Funder

University of Birmingham Edgbaston campus

Commonwealth Scholarship Commission

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference88 articles.

1. Guideline for the Treatment of Malaria;World Health Organization,2015

2. Residual neurologic sequelae after childhood cerebral malaria;van Hensbroek;J. Pediatr.,1997

3. Cerebral malaria and epilepsy;Ngoungou;Epilepsia.,2008

4. Cerebral malaria in children is associated with Long-term cognitive impairment;John;PEDIATRICS.,2008

5. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment;Newton;Pharmacol. Ther.,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified release, enriched biocompatibility, and enhanced oral bioavailability as precious features of nitrofurantoin-loaded polymeric nanoparticles;Journal of Drug Delivery Science and Technology;2024-11

2. Intranasal Delivery of Sulpiride Nanostructured Lipid Carrier to Central Nervous System; In Vitro Characterization and In Vivo Study;Pharmaceutical Development and Technology;2024-09-12

3. Ibrutinib topical delivery for melanoma treatment: The effect of nanostructured lipid carriers’ composition on the controlled drug skin deposition;Colloids and Surfaces B: Biointerfaces;2024-05

4. Malaria Therapeutic Paradigm: An Evolution Towards Commercial Drug Delivery Technology;Current Treatment Options in Infectious Diseases;2024-04-05

5. Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport;Pharmaceutics;2024-04-01